RGA Q3 2026: A Solid EPS Beat, Healthy ROE, and a Dividend-Driven Quarter

NYSE: RGA • Reinsurance Group of America, Incorporated • Third Quarter 2026 results

Earnings snapshot

EPS of $6.92 per diluted share for the quarter, up from $3.81 in the prior-year quarter.
Adjusted operating income of $8.49 per diluted share, vs. $4.66 in the prior-year quarter.
ROE (return on equity) of 13.1% on a trailing twelve-month basis; adjusted operating ROE of 19.2%; and adjusted operating ROE, excluding notable items, 19.1% for the last twelve months.
Shareholder returns: $139 million returned in the quarter, including $75 million in share repurchases and $64 million in dividends.
Net premiums for the quarter were $5.352 billion, supporting the top-line strength alongside other drivers.
currency fluctuations had a modest drag: an unfavorable effect of $0.11 per diluted share on net income and $0.15 per diluted share on adjusted operating income versus the prior-year quarter.

What the numbers say, in plain terms

RGA’s quarter reads like a disciplined, capital-light insurance swing: strong earnings per share, a respectable ROE profile, and a healthy cadence of returning capital to shareholders. The delta versus the prior year is large in absolute terms—EPS and adjusted operating income moved meaningfully higher—while the currency backdrop tempered the translated earnings by a few tenths of a dollar per diluted share. In other words, the company did the math, even if the foreign exchange bit tried to hide under the bed.

The ROE figures merit attention. A trailing twelve months ROE of 13.1% sits in the middle of what a diversified insurer might consider acceptable, but the 19.2% adjusted operating ROE suggests substantial earnings power from the core reinsurance business when you exclude notable items. That implies a business with attractive returns on capital even after accounting for the usual float-and-capital-management considerations in a long-tail line of business.

Capital allocation and cadence

RGA’s quarterly cash return approach is deliberate rather than opportunistic. Returning $139 million to shareholders in the quarter—$75 million via share repurchases and $64 million through dividends—signals management’s confidence in the company’s cash generation and long-duration value proposition. In a sector where capital is both the product and the constraint, the ability to buy back shares while funding growth opportunities is a positive signal for equity holders.

The combination of strong net premiums, a waitful but constructive currency profile, and a robust capital returns program suggests RGA can sustain or even modestly grow its ROE profile if macro conditions cooperate. The “pipeline for both in-force and new business remains healthy,” according to management, hinting at upside if underwriting conditions stay supportive and risk pricing remains favorable.

Outlook and what it portends for the sector

Management framed the quarter as evidence of resilience across regions, with robust investment performance and favorable claims experience contributing to the stronger results. The forward-looking tone—positioning for continued strength through 2026 and beyond—suggests a sector dynamic where diversified platforms, disciplined capital deployment, and the ability to adapt to currency and macro headwinds will remain key differentiators.

From a peer perspective, RGA’s results reinforce a few takeaways for life and health reinsurance players: disciplined capital management matters as much as underwriting discipline, ROE remains a focal metric (and an area where adjustments for notable items can reveal underlying profitability), and the ability to translate investment skills into dividend and buyback capacity matters to equity investors.

What investors might be watching next

While the release does not publish a formal EPS consensus or a stated earnings surprise figure, the sizable year-over-year EPS expansion and the robust adjusted operating income point to a positive near-term read for RGA’s earnings trajectory. Analysts tracking the ticker (RGA) will likely weigh the impact of currency movements, the mix of in-force versus new business, and the durability of the pipeline in the remainder of 2026. A revenue forecast and guidance for 2027 would help anchor expectations, but the current tone already signals room for upside if market conditions remain favorable and if the company sustains its capital-return cadence.

Bottom line for investors: the combination of a higher EPS, a strong ROE backbone, and a steady dividend-and-buyback program makes RGA a compelling data point in the reinsurance space—particularly for those who value capital efficiency and multi-year horizon planning over quarterly noise. If the sector as a whole can maintain pricing power and manage tail risks, RGA’s results could echo across peers by highlighting the value of disciplined capital allocation in a volatile macro picture.

Pun placeholder for rhythm

Note to readers: this isn’t a policy to confuse. It’s a policy to reveal—the math behind the margin and the story in the numbers is what keeps the premium flowing and the shareholders smiling. In the insurance world, a good quarter is often less about luck and more about underwriting discipline, investment acumen, and a thoughtfully deployed capital plan.